Ramy Sedhom, MD, FASCO
@ramsedhom
Associate Dir, PC3I & Director, Program in Geriatric Oncology & Supportive Care Innovation, PC3I Assistant Professor at Penn Medicine
1/6 Our JCO piece @guptaarjun90 on the need to improve communication training in #medonc fellowship. Every day oncologists deliver bad news. The words we choose impact pts & caregivers. Our training does not reflect the gravity of this @tmprowell @AAHPM ascopubs.org/doi/full/10.12…
Quality Improvement Effort With Proactive Social Worker Communication to Enhance #Palliative Care Access. ascopubs.org/doi/10.1200/OP… @ASCO @JCO_ASCO @JCOOP_ASCO #PallOnc #SuppOnc #PalliativeCare
Very proud to celebrate nearly 1 year of our psychosocial oncology program @PennMedicine @PrincetonHealth

NEW in @JAMANetworkOpen: How do oncologists react to @US_FDA Accelerated vs. Traditional Approval? Answer - MUCH more robustly to AA! Using @flatironhealth data, we show that prescribing increases 23 vs. 1 percentage-points after AA vs. after TA. -> jamanetwork.com/journals/jaman…
Curiosity question from my thoracic colleagues: why in the ASCO Guideline for mesothelioma is there an age cut off for consideration of use of avastin?

Our paper explores the barriers to #PallCare delivery in LMICs & how closely providers adhere to @ASCO guidelines @JCOGO_ASCO Timely insights to support equity in global cancer care @BillyRosaPhD @realbowtiedoc @MazieTsangMD @ramsedhom @DarcyBurbage 📖: ascopubs.org/doi/full/10.12…
Navigating Challenges in #PalliativeCare: A Survey on ASCO Guideline Adherence Among Health Care Providers in Low- and Middle-Income Countries. Read the full article. brnw.ch/21wTlBC
Fantastic view and such a great model for everyone that looks up to him. You can be passionate about your career, set high goals, etc. without it being your entire life. Remember to have perspective on what truly makes your ❤️ happy and your life fulfilled.
Scottie Scheffler just gave one of the best (and deepest) press conference answers ever heard.
Our team @PennMedicine @PennCancer is recruiting two medical oncologists for our Princeton site in New Jersey. I am leading the recruitment efforts. Focus areas include Breast, GU, and Hematologic Malignancies. Please message me if interested or if you'd like to learn more
Effective geriatric assessment-guided care can be delivered virtually, expanding its reach. Alongside standard oncology care, it improves the function of older adults w/ cancer. Early and integrated assessment matters. #gerionc @crisbergerot @WilliamDale_MD @myCARG
📢 Just published in @JNCCN ! Our RCT shows that a telehealth GA & #SuppCare Intervention (GAIN-S) improved physical function, mood & QoL in older Brazilians with metastatic cancer @WilliamDale_MD @EnriqueSoto8 @Areejmd @RyanNipp jnccn.org/view/journals/…
.@PrincetonHealth's #GeriatricOncology Program has been honored with the 2025 Innovator Award by @ACCCBuzz. Their work was recognized at ACCC’s 42nd National Oncology Conference for advancing compassionate, age-inclusive cancer care. spr.ly/60184JzYi @ramsedhom #GeriOnc
📢 Just published in @JNCCN ! Our RCT shows that a telehealth GA & #SuppCare Intervention (GAIN-S) improved physical function, mood & QoL in older Brazilians with metastatic cancer @WilliamDale_MD @EnriqueSoto8 @Areejmd @RyanNipp jnccn.org/view/journals/…
🎗️ Cancer & Aging: What Every Family Should Know 🗓️ June 13 | 7:30 AM–12:30 PM 📍 Mercer County Community College Free event for patients & families: expert talks, breakout sessions, real stories, support resources. 🔗 Register: pennmedicine.trumba.com/princeton-heal… #CancerCare #AgingAndCancer…

Urgent need for updated guidelines on Systemic Anticancer Therapy use at #EndofLife: Our study of 68,000+ patients found use of novel SACT at EOL, including immunotherapy, was associated with indicators of poor-quality #EndofLifeCare. doi.org/10.1200/JCO-24… @JCO_ASCO @thePMCF
#ASCO25 First RCT on steroid duration in mild ICI-pneumonitis 3-w vs 6-w corticosteroid therapy 👥 n:105 (G 1–2 pneumonitis) ✅ Tx success at 8 wks: 66.7% vs 85.2% → Non-inferiority not met❗️ 🔁 Relapse rate: 41% vs 24% ❗️Shorter 3-week regimen cannot replace standard…